Table 2.
Baseline prevalence, follow-up prevalence, incidence rate, and remission rate of MetS components, based on Harmonized Criteria.
| Outcome | |||||||
|---|---|---|---|---|---|---|---|
| ≥1 MetS | Elevated TG | Elevated BP | Elevated WC | Reduced HDL | Elevated FPG | ||
| Baseline | n/N | 347/1182 | 87/1182 | 55/1182 | 21/1182 | 211/1182 | 41/1182 |
| % | 29.4 | 7.4 | 4.7 | 1.8 | 17.9 | 3.5 | |
| Follow-up | n/N | 475/1182 | 120/1182 | 142/1182 | 105/1182 | 250/1182 | 28/1182 |
| % | 40.2 | 10.2 | 12.0 | 8.9 | 21.2 | 2.4 | |
| Incidence | per 1000 | 327 | 76 | 103 | 82 | 166 | 18 |
| Remission | per 1000 | 418 | 575 | 527 | 524 | 578 | 829 |
MetS, metabolic syndrome; TG, triglyceride; TyG, TG–glucose index; BP, blood pressure; WC, waist circumference; HDL, high-density lipoprotein; FPG, fasting plasma glucose; n, number of diseased individuals; N, number of individuals at risk.